HOME > News Releases

News Releases

2015.09.01
Corporate
PDF/54KB
Sumitomo Dainippon Pharma announces personnel change
2015.08.28
Products
PDF/184KB
Sunovion Announces FDA Approval of a New Indication for Aptiom (eslicarbazepine acetate) as Monotherapy for Partial-Onset Seizures
2015.07.29
Finances
PDF/309KB
Supplementary Financial Data for the First Quarter of the Year Ending March 31, 2016
2015.07.29
Finances
PDF/152KB
Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2016[Japanese GAAP](Unaudited)
2015.07.24
R&D
PDF/223KB
Sumitomo Dainippon Pharma, CiRA and Hitachi Start Joint Research on Development of Key Evaluation Technologies: Evaluation for Industrialization in the Field of Regenerative Medicine --- Toward Application of Human iPS Cell for Parkinson’s Disease Treatment ---
2015.07.15
Licensing
PDF/122KB
Sumitomo Dainippon Pharma Announces Commercialization Partnership with Servier on Its Atypical Antipsychotic Agent Latuda (lurasidone hydrochloride) for Australia
More News Releases

Page Top